Smith & Nephew Earnings, Revenue Beat in Q2
- ByInvesting.com-
Investing.com - Smith & Nephew reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Smith & Nephew announced...
Investing.com - Smith & Nephew reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Smith & Nephew announced...
By Andrew Chung (Reuters) -The U.S. Supreme Court on Monday allowed a U.S. Patent and Trademark Office tribunal that has gained a reputation for canceling patents to continue...
By Andrew Chung (Reuters) - U.S. Supreme Court justices on Monday signaled they may rein in the power of in-house judges serving on a U.S. Patent and Trademark Office tribunal who...
Stocks of medical technology firms manufacturing and marketing health-care products have had a mixed year. In the wake of the outbreak of the coronavirus pandemic, elective...
Integer Holdings Corporation (NYSE:ITGR) is well poised for growth on portfolio management, strong presence in the broader MedTech space and improving Non-Medical sales. However,...
Abbott Laboratories (NYSE:ABT) reported fourth-quarter 2019 adjusted earnings from continuing operations of 95 cents per share, in line with the Zacks Consensus Estimate....
Smith & Nephew plc is a medical technology company. The Company is engaged in designing and manufacturing technology. It supports healthcare professionals to return their patients to health and mobility by helping them to perform. It serves its customers through global franchises, which includes Orthopaedics, Sports Medicine and Ear, Nose and Throat (ENT) and Advanced Wound Management. The Orthopaedics includes a range of Hip and Knee Implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that allow surgeons, and Trauma products used to stabilize severe fractures and correct bone deformities. Its Sports Medicine and ENT businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a set of products to meet clinical needs, to help healthcare professionals reduce the human and economic consequences of wounds.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Buy | Sell | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Neutral | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 524.20 | 528.87 | 516.19 | -2.16 | -0.41% | 2.46M | NASDAQ | |||
| 91.16 | 93.42 | 89.62 | -3.91 | -4.11% | 122.34M | NASDAQ | |||
| 74.67 | 74.92 | 72.17 | +2.12 | +2.92% | 11.09M | NYSE | |||
| 62.14 | 65.16 | 61.18 | -4.79 | -7.16% | 1.45M | NASDAQ | |||
| 179.12 | 180.45 | 175.62 | -1.57 | -0.87% | 2.19M | NASDAQ | |||
| 167.82 | 168.26 | 165.16 | +2.22 | +1.34% | 6.21M | NASDAQ | |||
| 2.55 | 2.83 | 2.55 | -0.34 | -11.76% | 25.55M | NASDAQ | |||
| 0.625 | 1.03 | 0.59 | +0.0200 | +3.31% | 41.90M | NASDAQ | |||
| 2,050.06 | 2,094.74 | 2,019.34 | -56.59 | -2.69% | 337.45K | NASDAQ | |||
| 0.00 | 0.00 | 0.00 | 0.000 | 0.00% | 0.00 | OTC Markets | |||
| 54.50 | 55.32 | 53.56 | -1.39 | -2.49% | 4.99M | NASDAQ | |||
| 52.01 | 52.14 | 51.96 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 34.14 | 34.66 | 33.07 | -0.68 | -1.95% | 161.37K | NASDAQ | |||
| 100.29 | 101.51 | 97.04 | -1.20 | -1.18% | 2.33M | NYSE | |||
| 9.77 | 9.77 | 9.77 | 0.000 | 0.00% | 806.00 | NASDAQ |